Giotrif Description

GIOTRIF 20 mg: White to slightly yellowish, round, biconvex, bevel-edged film-coated tablet debossed with the code T20 on one side and the Boehringer Ingelheim company symbol on the other side.
GIOTRIF 30 mg: Dark blue, round, biconvex, bevel-edged film-coated tablet debossed with the code T30 on one side and with the Boehringer Ingelheim company symbol on the other side.
GIOTRIF 40 mg: Light blue, round, biconvex, bevel-edged film-coated tablet debossed with the code T40 on one side and with the Boehringer Ingelheim company symbol on the other side.
One film-coated tablet contains 20 mg, 30 mg, or 40 mg of afatinib (as dimaleate).
Excipient with known effect: GIOTRIF 20 mg: One film-coated tablet contains 118 mg lactose (as monohydrate).
GIOTRIF 30 mg: One film-coated tablet contains 176 mg lactose (as monohydrate).
GIOTRIF 40 mg: One film-coated tablet contains 235 mg lactose (as monohydrate).
Excipients/Inactive Ingredient: Tablet Core: Lactose monohydrate, microcrystalline cellulose (E460), colloidal anhydrous silica (E551), crospovidone, magnesium stearate (E470b).
Film-coating: Hypromellose 2910 (E464), macrogol 400, titanium dioxide (E171), talc (E553b), polysorbate 80 (E433), Colourant containing indigo carmine (E132) aluminium hydroxide (only used for 40 mg and 30 mg tablets).
Lactose: GIOTRIF contains lactose. Patients with rare hereditary conditions of galactose intolerance, the Lapp lactase deficiency or glucose-galactose malabsorption should not take this medicine.